Global Cancer Immunotherapies Market To Grow At a CAGR of 15.17% During Years 2016-2020

“The Latest Research Global Cancer Immunotherapies Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.

Technavios analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.

Get Sample copy of this Report @

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.

The market is divided into the following segments based on geography:




Technavio’s report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


Bristol-Myers Squibb

F. Hoffmann-La Roche



Takeda Pharmaceuticals

Other prominent vendors


ADC Therapeutics






Biotech Pharmaceutical



Celldex Therapeutics

Chugai Pharmaceutical

CTI Biopharma

Daiichi Sankyo

Eli Lilly

Fortress Biotech



Intas Pharmaceuticals

Janssen Biotech

Kyowa Hakko Kirin



Neovii Biotech


OncoMed Pharmaceuticals



Seattle Genetics

Spectrum Pharmaceuticals

TG Therapeutics


View Sample PDF @

Market driver

Increase in demand for cancer monoclonal antibodies

For a full, detailed list, view our report

Market challenge

Patent expiry of top-selling drugs

For a full, detailed list, view our report

Market trend

Emergence of targeted and combination therapies

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Send An Enquiry Request @

Table Of Contents

PART 01: Executive summary


PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Overview of cancer immunotherapies


Spending on cancer

Cost of cancer treatment

Reimbursement policies

Economic burden of cancer

Orphan drug designation and regulatory approvals

PART 06: Pipeline portfolio

Anticipated number of products with single and multi-indications by 2020

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by type

Cancer monoclonal antibodies

Clinical trials of cancer monoclonal antibodies

Immune checkpoint inhibitors

Cancer vaccines

Non-specific immunotherapies

Global cancer monoclonal antibodies market

Global cancer vaccines market

Global immune checkpoint inhibitors market

Global non-specific immunotherapies market

PART 09: Geographical segmentation

Global cancer immunotherapies market by geography 2015-2020

Cancer immunotherapies market in Americas

Cancer immunotherapies market in EMEA

Cancer immunotherapies market in APAC

PART 10: Market drivers

Increase in prevalence of cancers

Increase in demand for cancer monoclonal antibodies

Patient assistance programs

Promising pipeline

PART 11: Impact of drivers

PART 12: Market challenges

Patent expiry of top-selling drugs

Poor diagnosis and screening

High developmental costs

Risk of side-effects

Stringent regulations

PART 13: Impact of drivers and challenges

PART 14: Market trends

Increase in cancer awareness

Emergence of targeted and combination therapies

Emergence of biosimilars

Strategic alliances

Buy Now This Report From Here @

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by
%d bloggers like this: